Sign in
4

Changes in Ownership

aTYR PHARMA INC Filed Acc 0001209191-17-027776

CEO and Director bought 2,552 shares at $3.00 ($7,656)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
MENDLEIN JOHN CEO and Director 2017-04-18 Purchase +1,000 $3.00 $3,000 325,971 D
MENDLEIN JOHN CEO and Director 2017-04-20 Purchase +1,552 $3.00 $4,656 327,523 D
Open-market purchases · 2,552 sh · avg $3.00 · $7,656
Loading xslF345X03/doc4.xml…